Resection of Persistent Stage IIIA-N2 Non-small Cell Lung Cancer After Induction Therapy

Affiliations

¹ Division of Thoracic Surgery, Swedish Cancer Institute, 1101 Madison St, #900, Seattle, WA 98104.
² Division of Thoracic Surgery, Swedish Cancer Institute, 1101 Madison St, #900, Seattle, WA 98104. Electronic address: adam.bograd@swedish.org.

Comment

Weston G Andrews et al. Ann Thorac Surg. 2022 Dec.

. 2022 Dec;114(6):2392-2393.

doi: 10.1016/j.athoracsur.2022.03.036. Epub 2022 Mar 26.

¹ Division of Thoracic Surgery, Swedish Cancer Institute, 1101 Madison St, #900, Seattle, WA 98104.
² Division of Thoracic Surgery, Swedish Cancer Institute, 1101 Madison St, #900, Seattle, WA 98104. Electronic address: adam.bograd@swedish.org.

No abstract available

Comment on

Persistent N2 After Induction Is Not a Contraindication to Surgery for Lung Cancer.
Andrews WG, Louie BE, Castiglioni M, Dhamija A, Farivar AS, Chansky J, White PT, Aye RW, Vallières E, Bograd AJ. Andrews WG, et al. Ann Thorac Surg. 2022 Aug;114(2):394-400. doi: 10.1016/j.athoracsur.2021.11.010. Epub 2021 Dec 8. Ann Thorac Surg. 2022. PMID: 34890568
Resection of Persistent N2 Lung Cancer After Induction Therapy.
Rami-Porta R, Call S, Obiols C. Rami-Porta R, et al. Ann Thorac Surg. 2022 Dec;114(6):2392. doi: 10.1016/j.athoracsur.2022.01.024. Epub 2022 Feb 8. Ann Thorac Surg. 2022. PMID: 35149048 No abstract available.